TY - JOUR
T1 - Erratum to
T2 - Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)
AU - Shivakumar, M.
AU - Jayashree, P.
AU - Najih, Muhammad
AU - Lewis, Leslie Edward Simon
AU - Ramesh Bhat, Y.
AU - Kamath, Asha
AU - Shashikala,
PY - 2017/10/1
Y1 - 2017/10/1
N2 - In Table II, P value in first row (against ‘continuing apnea’ at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against ‘continuing apnea’ at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.
AB - In Table II, P value in first row (against ‘continuing apnea’ at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against ‘continuing apnea’ at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.
UR - http://www.scopus.com/inward/record.url?scp=85032265300&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032265300&partnerID=8YFLogxK
U2 - 10.1007/s13312-017-1160-9
DO - 10.1007/s13312-017-1160-9
M3 - Comment/debate
AN - SCOPUS:85032265300
VL - 54
JO - Indian Pediatrics
JF - Indian Pediatrics
SN - 0019-6061
IS - 10
ER -